findmyKOL

Thomas Shoemaker, MD

Basic profile

Rush University Medical Center

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyNeurologyFocusNeurology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Thomas Shoemaker is a Neurology physician affiliated with Rush University Medical Center. OpenAlex indexes 28 publications with 255 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
28publications

Distinct works indexed by OpenAlex, matched via ORCID.

255citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1725 W Harrison St Ste 1106
Chicago, IL 606123845

Telephone

312-942-4500

Registry record last updated 6 Aug 2018.

View the NPPES registry record

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    63%
    Potassium Channel Blocker21.1%
    Dalfampridine Er95%Ampyra5%
    Part D<11 patients
    Gabapentinoids11.3%
    Gabapentin61%Pregabalin39%
    Part D30 patients

    + 15 more classes in this area

  • Musculoskeletal

    17.5%
    gamma-Aminobutyric Acid-ergic Agonist14.1%
    Baclofen100%
    Part D49 patients
    Central alpha-2 Adrenergic Agonist2%
    Tizanidine Hcl100%
    Part D<11 patients

    + 1 more class in this area

  • Cancer & immunology

    11.1%
    CD20-directed Cytolytic Antibody4.8%
    Kesimpta Pen100%
    Part D<11 patients
    Other immunosuppressants4.3%
    Tecfidera44%Dimethyl Fumarate38%Vumerity18%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”